Amyloid Imaging via Template Registration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting and quantifying amyloid deposits in the brain for diagnosing Alzheimer's disease are invasive, time-consuming, and prone to variability, particularly due to the need for arterial blood sampling and manual delineation of regions of interest in radiological images.

Innovation Solution

A method involving non-rigid registration of radiological brain images with positive and negative templates to generate metrics quantifying the closeness of image registration, allowing for more reliable and consistent assessment of amyloid deposits without relying on invasive procedures or extensive image processing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If kinetic modeling of dynamic PET time series with arterial blood sampling is used to quantify amyloid images, then measurement precision is improved, but the ease of operation deteriorates due to high invasiveness and extended patient immobilization requirements

Engineering Contradiction:
Improvequantification accuracyVSAvoidpatient comfort and procedural simplicity
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The patent extracts and eliminates the invasive arterial blood sampling component from the gold standard quantification method. Instead of requiring arterial catheterization and continuous blood draws, the invention uses alternative reference regions (such as pons or cerebellum) that can be identified on the PET images themselves, thereby removing the harmful invasive element while preserving quantification capability

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent creates a simplified copy of the quantification approach by using static images rather than dynamic time series. This copy maintains the essential quantification function but eliminates the need for extended scanning protocols and complex kinetic modeling, making the procedure more clinically feasible

Inventive Principle:
Principle #26Copying

2Measurement precision

If manual delineation of regions of interest is used in radiological images, then measurement precision can be maintained, but productivity deteriorates due to time-consuming procedures and substantial variability

Engineering Contradiction:
Improveregion identification accuracyVSAvoiddiagnostic throughput and reproducibility
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The patent implements automated segmentation algorithms that perform region of interest delineation without human intervention. The system uses image processing techniques to automatically identify and segment relevant brain regions based on intensity thresholds and anatomical patterns, making the method self-sufficient and eliminating manual labor

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent transforms the quantification approach by changing from manual coordinate-based delineation to automated intensity-based segmentation. This parameter change enables consistent, reproducible region identification across multiple images and operators while maintaining accuracy through algorithmic precision

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach provides a more reliable and efficient diagnostic tool for assessing amyloid deposits, reducing variability and the need for invasive procedures, while offering multiple independent quantification methods for consistency checks.

Implementation Method 1

administration of a radiotracer to the subject that binds to a target substance indicative of a clinical condition

Methodology Applied
Scientific EffectRadiotracer binding: Adsorption

Data Source

PatentUS10052076B2Diagnostic brain imaging
Publication Date: 2018.08.21 KONINKLIJKE PHILIPS NV
  • US10052076B2 patent drawing
  • US10052076B2 patent drawing
  • US10052076B2 patent drawing

AI summary

A radiological imaging apparatus (10) acquires a radiological brain image of a subject after administration of a radio tracer binding to a target substance indicative of a clinical pathology. In one embodiment, the clinical pathology is amyloid deposits in the brain at a level correlative with Alzheimer's disease and the target substance is amyloid deposits. A processor (C) tests for the clinical pathology by: performing non-rigid registration of the brain image with a positive template (32P) indicative of having the clinical pathology and with a negative template (32N) indicative of not having the clinical pathology; generating positive and negative result metrics (36P, 36N) quantifying closeness of the registration with the positive and negative template respectively; and generating a test result (54) based on the positive result metric and the negative result metric. An independent test result is generated by quantifying a second mode of an intensity histogram for the brain image.